Reference
Eworuke E, et al. Risk of Severe Abnormal Uterine Bleeding Associated with Rivaroxaban Compared with Apixaban, Dabigatran and Warfarin. Drug Safety : 20 May 2021. Available from: URL: http://doi.org/10.1007/s40264-021-01072-0
Rights and permissions
About this article
Cite this article
Increased risk of severe abnormal uterine bleeding associated with rivaroxaban. Reactions Weekly 1858, 10 (2021). https://doi.org/10.1007/s40278-021-96728-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-021-96728-4